Metraipolis › archive › dc_202bcf0be5ba
Characterizing and quantifying disease impacts of generalized myasthenia gravis (gMG) in the United States: insights from patient and caregiver interviews and… — Europe PMC PMID:42337141
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42337141
- DOI
- 10.1186/s41687-[numero omesso]-y
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T05:39:38.104Z
- SHA-256 of the archived text
27ae80852e0ff524322c46eaeff5ca9474bc8149b8b5a0a57d8648ef475f6e85- Stable URL of this page
https://metraipolis.com/documento/dc_202bcf0be5ba
How to cite
Characterizing and quantifying disease impacts of generalized myasthenia gravis (gMG) in the United States: insights from patient and caregiver interviews and… — Europe PMC PMID:42337141 — Europe PMC (en), https://europepmc.org/article/MED/42337141 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_202bcf0be5ba (Metraipolis archive dc_202bcf0be5ba, sha256 27ae80852e0ff524322c46eaeff5ca9474bc8149b8b5a0a57d8648ef475f6e85)
BibTeX
@misc{dc202bcf0be5ba,
title = {Characterizing and quantifying disease impacts of generalized myasthenia gravis (gMG) in the United States: insights from patient and caregiver interviews and… — Europe PMC PMID:42337141},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42337141},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_202bcf0be5ba; sha256 27ae80852e0ff524322c46eaeff5ca9474bc8149b8b5a0a57d8648ef475f6e85},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42337141. Agents can read the archived copy with the MCP tool read_document.